Zoetis Q4 Adjusted EPS $1.24 Misses $1.32 Estimate, Sales $2.21B Beat $2.19B Estimate
Portfolio Pulse from Benzinga Newsdesk
Zoetis reported Q4 adjusted EPS of $1.24, missing the $1.32 estimate, but its sales of $2.21B exceeded the $2.19B estimate. This represents a 7.83% increase in earnings and an 8.48% increase in sales from the same period last year.

February 13, 2024 | 12:02 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Zoetis missed Q4 EPS estimates but exceeded sales expectations, showing a year-over-year growth in both earnings and sales.
While Zoetis missed EPS estimates, the beat on sales and year-over-year growth in both metrics could balance investor sentiment. The miss on EPS might concern some investors, potentially putting downward pressure on the stock. However, the sales beat and growth rates could counteract this by demonstrating the company's overall health and growth trajectory. Therefore, a neutral impact is expected in the short term as these factors may balance each other out.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100